首页> 外文OA文献 >Did Oncotype DX® Recurrence Score Accurately Predict the Risk of Recurrence in Breast Cancer? A 10 Year Period Study in a Single Institution

【2h】

Did Oncotype DX® Recurrence Score Accurately Predict the Risk of Recurrence in Breast Cancer? A 10 Year Period Study in a Single Institution

机译：OncotypeDX®复发评分是否准确地预测乳腺癌复发的风险？一个机构的10年期间研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Vanda Farahmand Torous; Sophia K Apple;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Ki-67指数、孕激素受体表达、组织学分级和肿瘤大小预测乳腺癌复发风险的价值:一项连续的队列研究 [J] . 张燕娜, 周易冬, 茅枫, 癌症（英文版） . 2021,第006期
2. Did Oncotype DX? Recurrence Score Accurately Predict the Risk of Recurrence in Breast Cancer? A 10 Year Period Study in a Single Institution [J] . Torous Vanda Farahmand, Apple Sophia K Open Medicine Journal . 2015,第1期

机译：是Oncotype DX吗？复发评分能准确预测乳腺癌的复发风险吗？单一机构的十年研究
3. Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer [J] . Dodson Andrew, Okonji David, Assersohn Laura, Breast cancer research and treatment. . 2018,第1期

机译：Oncotype DX复发评分和RSPC之间的不等调，用于预测ER阳性乳腺癌复发的残留风险
4. Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer [J] . Dodson Andrew, Okonji David, Assersohn Laura, Breast cancer research and treatment. . 2018,第1期

机译：Oncotype DX复发评分和RSPC之间的不等调，用于预测ER阳性乳腺癌复发的残留风险
5. Prediction of Oncotype DX recurrence score in breast cancer by integration of DCE-MRI radiomics and clinicopathologic data [C] . Yajing Cui, Ming Fan, Weijun Peng, Conference on Medical Imaging: Imaging Informatics for Healthcare, Research, and Applications . 2021

机译：DCE-MRI辐射瘤和临床病理数据集成乳腺癌在乳腺癌中的癌型DX复发评分的预测
6. Fear of breast cancer recurrence, resilience, and age as predictors of posttraumatic growth in breast cancer survivors [D] . Teixeira da Silva, Maria A. 2015

机译：担心乳腺癌复发，适应力和年龄是乳腺癌幸存者创伤后生长的预测指标
7. Risk stratification of ER‐positive breast cancer patients: A multi‐institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX® recurrence score 26 [O] . Bradley M. Turner, Mary Ann Gimenez‐Sanders, Armen Soukiazian, 2019

机译：ER阳性乳腺癌患者的风险分层：Rochester改良Magee算法（RoMMa）的多机构验证和结果研究以及OncotypeDX®复发评分26的预测
8. Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score [O] . Sunitha B. Thakur, Manuela Durando, Soledad Milans, 2017

机译：3.0T DW-MRI的雌激素受体阳性和淋巴结阴性侵袭性乳腺癌的表观扩散系数：癌型DX试验复发得分的潜在预测因子

Did Oncotype DX® Recurrence Score Accurately Predict the Risk of Recurrence in Breast Cancer? A 10 Year Period Study in a Single Institution

著录项

引文网络

相似文献

相关主题

期刊订阅